Cargando…
Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma
Tumor cells induce an immunosuppressive microenvironment which leads towards tumor immune escape. Understanding the intricacy of immunomodulation by tumor cells is essential for immunotherapy. Indoleamine 2,3-dioxygenase (IDO) is an immunosuppressive enzyme which mediates tumor immune escape in vari...
Autores principales: | Asghar, Kashif, Farooq, Asim, Zulfiqar, Bilal, Rashid, Muhammad Usman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385395/ https://www.ncbi.nlm.nih.gov/pubmed/28428708 http://dx.doi.org/10.3748/wjg.v23.i13.2286 |
Ejemplares similares
-
Indoleamine 2,3-Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma
por: Farooq, Asim, et al.
Publicado: (2023) -
Review of 10 years of research on breast cancer patients: Focus on indoleamine 2,3-dioxygenase
por: Asghar, Kashif, et al.
Publicado: (2021) -
Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors
por: Zulfiqar, Bilal, et al.
Publicado: (2017) -
High Indoleamine 2,3-Dioxygenase Expression along with Low Bridging Integrator-1 Expression in Hepatocellular Carcinoma Patients
por: Asghar, Kashif, et al.
Publicado: (2023) -
Association between Cyclooxygenase-2 and Indoleamine 2,3-Dioxygenase Expression in Breast Cancer Patients from Pakistan
por: Asghar, Kashif, et al.
Publicado: (2019)